These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1427553)

  • 21. Quality of life in patients with Parkinson's disease.
    Behari M; Srivastava AK; Pandey RM
    Parkinsonism Relat Disord; 2005 Jun; 11(4):221-6. PubMed ID: 15878582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled study of dementia in Parkinson's disease over 54 months.
    Mindham RH; Biggins CA; Boyd JL; Harrop FM; Madeley P; Randall JI; Spokes EG
    Adv Neurol; 1993; 60():470-4. PubMed ID: 8420172
    [No Abstract]   [Full Text] [Related]  

  • 23. [Exercices program and rehabilitation of motor disorders in Parkinson's disease].
    Pélissier J; Pérennou D
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():190-200. PubMed ID: 10916050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical course of patients with idiopathic Parkinson's disease.
    Roos RA; Jongen JC; van der Velde EA
    Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activating ergotherapy--a method for increasing cognitive performance in geriatric patients].
    Bach D; Böhmer F; Frühwald F; Grilc B
    Z Gerontol; 1993; 26(6):476-81. PubMed ID: 8147083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical observations in early and late onset Parkinson's disease.
    Bostantjopoulou S; Logothetis J; Katsarou Z; Mentenopoulos G
    Funct Neurol; 1991; 6(2):145-9. PubMed ID: 1916456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
    van Hilten JJ; van der Zwan AD; Zwinderman AH; Roos RA
    Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acupuncture therapy for the symptoms of Parkinson's disease.
    Shulman LM; Wen X; Weiner WJ; Bateman D; Minagar A; Duncan R; Konefal J
    Mov Disord; 2002 Jul; 17(4):799-802. PubMed ID: 12210879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rehabilitation and Parkinson's disease.
    Formisano R; Pratesi L; Modarelli FT; Bonifati V; Meco G
    Scand J Rehabil Med; 1992 Sep; 24(3):157-60. PubMed ID: 1411361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.
    Noe E; Marder K; Bell KL; Jacobs DM; Manly JJ; Stern Y
    Mov Disord; 2004 Jan; 19(1):60-7. PubMed ID: 14743362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT; Goetz CG
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
    Larsen JP; Boas J
    Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
    Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative responsiveness of Parkinson's disease scales to change over time.
    Schrag A; Spottke A; Quinn NP; Dodel R
    Mov Disord; 2009 Apr; 24(6):813-8. PubMed ID: 19199355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E; González M; Aguilar A; Quintana S
    Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-deprenyl therapy in Thai patients with Parkinson's disease: before and after, clinical trial of 50 patients.
    Poungvarin N; Viriyavejakul A
    J Med Assoc Thai; 1990 Jul; 73(7):381-6. PubMed ID: 2123233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson disease: an update.
    Gazewood JD; Richards DR; Clebak K
    Am Fam Physician; 2013 Feb; 87(4):267-73. PubMed ID: 23418798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.